Effects of the angiotensin-receptor blocker telmisartan on cardiovascular events in high-risk patients intolerant to angiotensin-converting enzyme inhibitors: a randomised controlled trial
S Yusuf, K Teo, C Anderson, J Pogue, L Dyal, I Copland, H Schumacher, G Dagenais, P Sleight
The Lancet | ELSEVIER SCIENCE INC | Published : 2008
The study was supported by a grant from Boehringer Ingelheim. S Yusuf was supported by the Heart and Stroke Foundation of Ontario, and a Senior Scientist Award from the Canadian Institutes of Health Research. We thank Judy Lindeman for secretarial assistance.